In vitro and in vivo studies have demonstrated that binding of GAD by anti-GAD antibodies suppresses GABA release with an epitope dependence, leading to the development of cerebellar ataxia, thus suggesting that GAD antibodies may be implicated in the pathophysiology of anti-GAD ataxia [15]. The gene discussed is GAD1; the disease is cerebellar ataxia.